Close this search box.
Close this search box.

October 31, 2022

Lance Hill on the Pharmaceutical Commerce podcast

Life science companies should look at a modern, tech-enabled process for gathering insight.
within3 pharmaceutical commerce podcast

Within3 CEO Lance Hill recently appeared on the Pharmaceutical Commerce podcast to discuss the insight gap, pharma’s biggest challenges, the importance of diversity and inclusion in drug development, and how artificial intelligence is changing the industry’s work.

During the discussion, Hill highlighted how life science companies traditionally look at the insight-gathering process versus how they should be looking at it now – in other words, why a fragmented and slow approach needs to be replaced by a modern, tech-enabled process. “It’s very siloed, and it’s very, very expensive,” says Hill. “You have a lot of vendors, a lot of extra services involved…and the fact that the whole process is not integrated makes it really inefficient.”

These inefficiencies can multiply throughout developing and marketing a drug, particularly regarding accounting for the diverse populations life science companies serve. Pharmaceutical and medical device companies are increasingly addressing these issues with insights management technology, including network analytics and social listening, asynchronous engagement, and artificial intelligence.

“A lot of AI in life science historically, especially in a clinical R&D space, has been focused on structured data…[but] most insights that come in are unstructured text.” Hill explains, “AI helps you take all those inputs from all your field interactions, group interactions, or assessments you may take…bring it all together and analyze it in real-time.”

Listen to the 20-minute podcast.

Related Posts:

virtual engagement predictions

Within3 in PharmaTimes: What role for virtual engagement in 2022?

Lance Hill in the Journal of MHealth

Within3 in Journal of mHealth: bridge the insight gap

Within3 in The Wall Street Journal

More insights, direct to your inbox.